Ignite Creation Date:
2024-05-06 @ 6:33 PM
Last Modification Date:
2024-10-26 @ 2:50 PM
Study NCT ID:
NCT05703724
Status:
COMPLETED
Last Update Posted:
2023-05-31
First Post:
2023-01-19
Brief Title:
Prevalence of Glaucoma in Belgium a Multicenter National Trial
Sponsor:
Universitaire Ziekenhuizen KU Leuven
Organization:
Universitaire Ziekenhuizen KU Leuven
Study Overview
Official Title:
Prevalence of Glaucoma in Belgium a Multicenter National Trial
Status:
COMPLETED
Status Verified Date:
2023-01
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
BelGlaucoma
Brief Summary:
To screen for the presence of glaucoma in a Belgian population over 40 years old using an AI algorithm developed for the detection of glaucoma based on fundus pictures
Detailed Description:
In this study we aim to detect individuals with glaucoma and refer them for further evaluation and treatment when necessary In so doing we want to get an estimation of the prevalence of glaucoma in the Belgian population of 40 years
A fundus picture will be acquired without pupil dilation This examination will be followed by an intra-ocular pressure measurement The results will be discussed with the participating subject by the present physician For each subject both eyes will be evaluated In case of suspected glaucoma the subject will be referred to an ophthalmologist for further evaluation
A fundus picture will be acquired without pupil dilation This examination will be followed by an intra-ocular pressure measurement The results will be discussed with the participating subject by the present physician For each subject both eyes will be evaluated In case of suspected glaucoma the subject will be referred to an ophthalmologist for further evaluation
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None